Eversept Partners, LP Amarin Corp Plcuk Transaction History
Eversept Partners, LP
- $904 Million
- Q1 2025
A detailed history of Eversept Partners, LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Eversept Partners, LP holds 3,399,204 shares of AMRN stock, worth $39.4 Million. This represents 3.37% of its overall portfolio holdings.
Number of Shares
3,399,204
Previous 1,516,592
124.13%
Holding current value
$39.4 Million
Previous $727,000
4089.27%
% of portfolio
3.37%
Previous 0.07%
Shares
47 transactions
Others Institutions Holding AMRN
# of Institutions
154Shares Held
70.1MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$288 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$144 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$43.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.62MShares$30.4 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$29.1 Million5.52% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $4.67B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...